JOHN BELMONT to Bone Marrow
This is a "connection" page, showing publications JOHN BELMONT has written about Bone Marrow.
Connection Strength
0.095
-
Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survival. Stem Cells. 2004; 22(2):188-201.
Score: 0.033
-
Use of cell-free retroviral vector preparations for transduction of cells from the marrow of chronic phase and blast crisis chronic myelogenous leukemia patients and from normal individuals. Hum Gene Ther. 1992 Apr; 3(2):137-45.
Score: 0.014
-
Leukemia inhibitory factor improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo. J Exp Med. 1991 Oct 01; 174(4):837-45.
Score: 0.014
-
Murine leukemia inhibitory factor enhances retroviral-vector infection efficiency of hematopoietic progenitors. Blood. 1990 Sep 15; 76(6):1098-103.
Score: 0.013
-
Human adenosine deaminase expression in mice. Blood. 1990 May 15; 75(10):2085-92.
Score: 0.013
-
Correlation between CXCR4 and homing or engraftment of acute myelogenous leukemia. Cancer Res. 2004 Sep 15; 64(18):6832 author reply 6832-3.
Score: 0.009